West Pharma’s vial to IV bag admixture device cleared by FDA for drug transfer

Needle-free apparatus is suited for immediate use and can optimize pharmacy cleanroom time


West Pharmaceutical Services, Inc. has received FDA 510(k) clearance of its Vial2Bag Advanced 20mm Admixture Device, which enables reconstitution and transfer of a drug between a vial and an IV bag.

The needle-free device is suited for immediate use and can optimize pharmacy cleanroom time, while assisting in standardizing admixture systems to maximize the efficiency of point-of-care nursing and can be an effective solution for meeting USP <797> compounding requirements, according to the company.

Key features include:

  • Design: The device has a dual channel design to provide dedicated fluid pathways into and out of the IV bag and a vial spike design that improves the connection to the drug vial. Needle-free operation meets OSHA and NAPPSI sharps prevention guidance.
  • Patient Care: It provides a solution for just-in-time IV medication preparation, improving timeliness at point of care.
  • Waste Reduction: Universal compatibility with all manufacturers’ IV bags up to 250mL and is suitable for use with liquid and powder medications with standard 20mm closure vials, leading to reduced drug and IV fluid waste.

West Pharmaceutical Services is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Headquartered in Exton, PA, the company serves customers from locations in North and South America, Europe, Asia and Australia.